Valneva SE (VALN)
9.069
+0.17
(+1.90%)
USD |
NASDAQ |
May 31, 16:00
9.00
-0.07
(-0.76%)
After-Hours: 20:00
Valneva Total Assets (Quarterly): 543.00M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 543.00M |
December 31, 2023 | 508.55M |
September 30, 2023 | 550.99M |
June 30, 2023 | 589.63M |
March 31, 2023 | 643.36M |
December 31, 2022 | 666.33M |
September 30, 2022 | 686.14M |
June 30, 2022 | 757.44M |
December 31, 2021 | 925.42M |
June 30, 2021 | 886.70M |
March 31, 2021 | 673.03M |
December 31, 2020 | 552.45M |
September 30, 2020 | 528.54M |
June 30, 2020 | 437.89M |
March 31, 2020 | 305.04M |
December 31, 2019 | 296.53M |
September 30, 2019 | 274.24M |
June 30, 2019 | 283.28M |
March 31, 2019 | 273.72M |
December 31, 2018 | 262.99M |
September 30, 2018 | 203.74M |
June 30, 2018 | 209.82M |
March 31, 2018 | 229.94M |
December 31, 2017 | 227.15M |
September 30, 2017 | 225.87M |
Date | Value |
---|---|
June 30, 2017 | 226.73M |
March 31, 2017 | 212.19M |
December 31, 2016 | 218.71M |
September 30, 2016 | 227.70M |
June 30, 2016 | 233.35M |
March 31, 2016 | 280.33M |
December 31, 2015 | 300.86M |
September 30, 2015 | 308.65M |
June 30, 2015 | 317.50M |
March 31, 2015 | 314.73M |
December 31, 2014 | 276.67M |
September 30, 2014 | 305.04M |
June 30, 2014 | 332.05M |
March 31, 2014 | 331.86M |
December 31, 2013 | 351.28M |
September 30, 2013 | 326.42M |
June 30, 2013 | 319.66M |
December 31, 2012 | 70.97M |
June 30, 2012 | 75.20M |
June 30, 2012 | 75.20M |
December 31, 2011 | 94.66M |
June 30, 2011 | 114.88M |
December 31, 2010 | 105.73M |
June 30, 2010 | 67.02M |
December 31, 2009 | 65.71M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
274.24M
Minimum
Sep 2019
925.42M
Maximum
Dec 2021
561.59M
Average
551.72M
Median
Total Assets (Quarterly) Benchmarks
DBV Technologies SA | 145.90M |
Cellectis SA | 354.46M |
PHAXIAM Therapeutics SA (DELISTED) | -- |
Genfit SA | 192.20M |
Innate Pharma SA | 203.61M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 338.66M |
Shareholders Equity (Quarterly) | 204.35M |
Debt to Equity Ratio | 0.9589 |
Current Ratio | 2.638 |
Net Debt Paydown Yield | -3.27% |